FORM 3A - Director's/Chief Executive's Notice - Interests in Shares of Listed Corporation
 
Form Serial No: DA20161125000135
1. Name of listed corporation: Genscript Biotech Corporation 
2. Stock code: 01548
3. Class of shares: Ordinary Shares 
4. Number of issued shares in class: 1,688,091,437
5. Name of director (English) as printed on HKID/Passport:
(Surname) Wang
(Other names) Luquan
8. Name of director (Chinese): 王魯泉 
9. Chinese Character Code:
12. Date of relevant event: 22/11/2016
(dd/mm/yyyy)
13. Date when director became aware of the relevant event/ interest in the shares (if later):
 
14. Details of relevant event:
  Relevant event code describing circumstances Code describing capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price per share Average price per share Average consideration per share Consideration code
Long position  124  211  211  1,200,000  HKD      0.798  301 
 
15. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long Position1,043,966,80061.84
 
16. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long Position1,043,966,80061.84
 
17. Capacity in which interests disclosed in Box 16 are held (required for Initial Notification only):
Code describing capacityNumber of shares
205
Long position903,902,024
201
Long position3,886,640
211
Long position1,043,966,800
 
18. Further information in respect of derivative interests in listed corporation:
Code describing derivatives Exercise period Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsPrice for grantExercise pricePrice on assignment 
Long Position40910/02/201331/07/20191.000.103 3,886,640
 
19. Further information in relation to interests of children under 18 and/or spouse:
Name of child/spouseNumber of shares
Nil 
 
20. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling shareholder% controlDirect interestNumber of shares
Genscript CorporationSuite 606, 1220 N. Market Street, Wilmington, DE 19801, County of New Castle, USAWang Luquan23.24Y
Long position903,902,024
Genscript CorporationSuite 606, 1220 N. Market Street, Wilmington, DE 19801, County of New Castle, USAZhang Fangliang40.59Y
Long position903,902,024
Genscript CorporationSuite 606, 1220 N. Market Street, Wilmington, DE 19801, County of New Castle, USAWang Ye11.76Y
Long position903,902,024
 
21. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
Nil 
 
22. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
Nil  
 
23. Further information from a party to an agreement under Section 317:
Names of other partiesAddressNumber of shares
Mr Zhang FangliangAddresses of individuals are not displayed.0
Ms Wang YeAddresses of individuals are not displayed.136,178,136
Total number of shares in which substantial shareholder is interested under section 317 and 318: 1,043,966,800
 
24. Date of filing this Form 3A: 25/11/2016
(dd/mm/yyyy)
26. Number of attachments: 0